Chang Liu, MD, PhD

Specializes In
  • Pathology
Languages Spoken
  • English


Sees Patients For

HLA testing, pretransfusion testing, antibody-mediated rejection, alloimmunization after blood transfusion and organ transplantation


Academic Title(s)

Associate Professor, Pathology & Immunology
Director, HLA Fellowship

Research Interests

Methodology development in HLA typing and serology testing; HLA epitope mismatch and transplant outcome; novel therapies for HLA sensitization and antibody-mediated rejection; HLA and disease association

Publications & Research

View research profile »


Fellowship: Histocompatibility and Immunogenetic

2016 Barnes-Jewish Hospital / Washington University School of Medicine

Fellowship: Transfusion Medicine

2014 Washington University School of Medicine

Residency: Clinical Pathology

2014 Washington University School of Medicine


2010 Vollum Institute, Oregon Health and Science University

Medical Degree

2004 Peking Union Medical College, Bejing, China

Financial Disclosures
  • Antiger Therapeutics
    • Equity: Yes
    • Reporting Date: 05/01/2023

Washington University and its physicians and health professionals are committed to ensuring integrity and objectivity in medical decision-making. Some of our physicians and health professionals work collaboratively with pharmaceutical, medical device or other medical care related companies to develop innovative ideas and products that can improve health care delivery and clinical outcomes for patients. In some instances, our physicians and health professionals have an ownership or potential ownership interest in a commercial company; and/or are paid by a commercial company to provide advice on product design or to speak about the use of medications, devices, equipment or procedures. These payments may include: a) compensation for consulting and speaking engagements, b) equity, and/or c) royalties for products invented by our faculty. Any payments to Washington University physicians or health professionals must be based on tangible services and may not exceed fair market value for their work. In addition to disclosure on this website, physicians and health professionals earning more than $10,000 per year must disclose their corporate financial relationship in writing to patients when prescribing or using that company's products.